SLC1A2 and neuromyelitis optica: Thus, differences in the extent of injury in NMO brain lesions may be attributable to variable expression of complement-regulatory protein or EAAT2 and the extent of complement activation, which is determined by the M1:M23 ratio, depending on the tissue involved [26], [29].